Cantharidin
Sponsors
GlaxoSmithKline, Queen Mary University of London, Montefiore Medical Center, Steven R Cohen, Wayne State University
Conditions
Arthritis, RheumatoidCardiovascular FunctionCommon WartsCommon Warts (Verruca Vulgaris)Human Papilloma Virus (HPV)InflammationMolluscum ContagiosumWart, Genital
Early Phase 1
Investigation of the Influence of Gender on Cardiovascular Function
CompletedNCT01582321
Start: 2012-03-31End: 2017-01-31Target: 56Updated: 2017-06-14
Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women
RecruitingNCT05597098
Start: 2022-12-12End: 2027-12-12Target: 34Updated: 2026-01-07
Phase 1
Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides
CompletedNCT01026064
Start: 2009-06-04End: 2009-11-27Updated: 2017-07-25
Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects
CompletedNCT03306589
Start: 2017-08-11End: 2018-06-20Updated: 2019-08-08
First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
TerminatedNCT03426995
Start: 2018-03-13End: 2019-05-02Updated: 2020-12-02
Phase 2
Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum
CompletedNCT02665260
Start: 2012-07-31End: 2016-01-31Updated: 2017-05-05
Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2
CompletedNCT03017846
Start: 2016-09-30End: 2017-09-06Updated: 2019-01-30